Drug intelligence / Profile preview

SHAPE10

Development stage: Unknown
Lead developer: Hugel
Modality: Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration: Injection

Overview

SHAPE10 is a cross-linked hyaluronic acid (HA) filler developed by Hugel, specifically designed for male aesthetic enhancement. It is indicated for penile enlargement (augmentation), providing a non-surgical option for increasing girth. The product utilizes the high viscosity and elasticity of cross-linked hyaluronic acid to provide immediate physical volumization and structural support upon injection into the penile fascia. SHAPE10 received regulatory approval in South Korea in 2017, expanding Hugel's portfolio of medical aesthetic products beyond facial fillers and botulinum toxins.

Brand names: SHAPE10SHAPE-10SHAPE 10

Beyond the preview

Go deeper on SHAPE10.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SHAPE10.

Explore the full profile